actual product may vary Zepbound (Tirzepatide) is a once-weekly injectable medication for adults with obesity or overweight
Does GLP-1 lower estrogen
Obesity is linked to lower testosterone through several mechanisms: excess adipose tissue converts testosterone to oestradiol via the enzyme aromatase, and obesity-related inflammation and insulin resistance can suppress the hypothalamic-pituitary-gonadal axis
At 40, other symptoms of low T cropped up, such as poor sleep, low energy, irritability, and weight gain
These gastrointestinal symptoms typically peak within the first few days after injection and diminish as the body adjusts
Most patients will notice changes within the first month, usually in terms of less hunger and a few pounds of weight loss